Italy · AIFA medicine catalogue
NUVAXOVID JN.1
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 051560011
- Form
- Dispersione per preparazione iniettabile
- Composition / generic term
- PROTEINA SPIKE RICOMBINANTE DI SARS-COV-2 (OMICRON JN.1) CON ADIUVANTE MATRIX-M
- Company as listed by source
- SANOFI WINTHROP INDUSTRIE
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica limitativa, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti
Source-listed ingredients
- PROTEINA SPIKE RICOMBINANTE DI SARS-COV-2 (OMICRON JN.1) CON ADIUVANTE MATRIX-M — 5 microgrammi
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mcg - Dispersione per preparazione iniettabile - Uso intramuscolare - Flaconcino (vetro) 0,5 ml (1 dose) - 10 flaconcini monodose (10 dosi)
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →